trial · primary record
NI112
Amyotrophic Lateral Sclerosis (ALS)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2028-03-01 |
| Primary endpoint | Number of Participants With incidence and severity of treatment-emergent adverse events |
| Registry ID | NCT07906665 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:26.790Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07906665
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.